BC7-32454-67709

3 vaccinations 6 coded responses 37 check-ins 6 free-text entries 3 call cases

Sex: Female
Age at first dose: 21-25
ZIP prefix: 785 / TX
Registered: 2021-04-21

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-20
Dose 1 — Pfizer-BioNTech
2021-04-21
Registered in v-safe
2021-04-21
Survey response — days 1–6 daily, dose 1
MedDRA: Muscle spasms — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache · Be unable to do your normal daily activities

Free text: Muscle spazing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-22
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Fatigue or tiredness

Adult check-in
2021-04-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fever · Fatigue or tiredness · Be unable to work

Adult check-in
2021-04-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-04-25
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Poor

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-26
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Fair

Free text: Dizzyness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-29
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-05-04
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-05-11
Dose 2 — Pfizer-BioNTech
2021-05-11
Health check-in — day 0, dose 2
Feeling: Poor · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-05-12
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-05-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea

Adult check-in
2021-05-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work

Adult check-in
2021-05-18
Health check-in — day 7, dose 2
Feeling: Fair · Fever · Headache, Fatigue or tiredness

Adult check-in
2021-05-25
Survey response — day 14, dose 2
MedDRA: Vertigo — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Symptoms of vertigo

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-25
Report sent to call center — day 14, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-01
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-06-10
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-06-15
Survey response — day 35, dose 2
MedDRA: Loss of consciousness — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Passing out

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-15
Report sent to call center — day 35, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-21
Call 1 — Could Not Reach Participant
2021-06-22
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-06-24
Call 2 — Could Not Reach Participant
2021-08-10
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-11-09
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-26
Dose 3 — Pfizer-BioNTech
2021-11-27
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-11-29
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2021-11-30
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-12-01
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-12-02
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Vomiting, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-12-03
Health check-in — day 7, dose 3
Feeling: Fair · None

Adult check-in
2021-12-10
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2021-12-17
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-26
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-31
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-01-07
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-02-27
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-05-29
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-11-26
Survey response — 12 months, dose 3
MedDRA: Pre-eclampsia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Preeclampsia

MedDRA releases: 2024-11 · check-in free text available
2022-11-26
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Hospitalization · 1 call case(s)
2022-11-28
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-11-28
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-11-28
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-20	Pfizer-BioNTech
2	2021-05-11	Pfizer-BioNTech
3	2021-11-26	Pfizer-BioNTech	No

Call center

3 call center cases

3 successful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-21

Systemic reaction (other): Muscle spazing

2021-04-25

Systemic reaction (other): Dizziness

Release 8 — days 1–6 daily, dose 1

2021-04-26

Systemic reaction (other): Dizzyness

Release 8 — day 14, dose 2

2021-05-25

Symptoms: Symptoms of vertigo

Release 9 — day 35, dose 2

2021-06-15

Symptoms: Passing out

Release 12 — 12 months, dose 3

2022-11-26

Symptoms: Preeclampsia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Loss of consciousness	✓	✓	✓
SD	Pre-eclampsia	·	·	✓
SD	Vertigo	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Muscle spasms	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release